These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17506784)

  • 21. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
    Hey JA; del Prado M; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
    Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
    BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
    Layton D; Key C; Shakir SA
    Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reference set of clinically relevant adverse drug-drug interactions.
    Kontsioti E; Maskell S; Dutta B; Pirmohamed M
    Sci Data; 2022 Mar; 9(1):72. PubMed ID: 35246559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports.
    Tatonetti NP; Fernald GH; Altman RB
    J Am Med Inform Assoc; 2012; 19(1):79-85. PubMed ID: 21676938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Torsades de pointes occurring in association with terfenadine use.
    Monahan BP; Ferguson CL; Killeavy ES; Lloyd BK; Troy J; Cantilena LR
    JAMA; 1990 Dec; 264(21):2788-90. PubMed ID: 1977935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports.
    Cai R; Liu M; Hu Y; Melton BL; Matheny ME; Xu H; Duan L; Waitman LR
    Artif Intell Med; 2017 Feb; 76():7-15. PubMed ID: 28363289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system.
    Jeong E; Nelson SD; Su Y; Malin B; Li L; Chen Y
    Front Pharmacol; 2022; 13():938552. PubMed ID: 35935872
    [No Abstract]   [Full Text] [Related]  

  • 30. Review of Statistical Methodologies for Detecting Drug-Drug Interactions Using Spontaneous Reporting Systems.
    Noguchi Y; Tachi T; Teramachi H
    Front Pharmacol; 2019; 10():1319. PubMed ID: 31780939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Torsade de pointes induced by cisapride/clarithromycin interaction.
    Piquette RK
    Ann Pharmacother; 1999 Jan; 33(1):22-6. PubMed ID: 9972380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Shared Electronic Health Record Systems on Drug-Drug Interaction and Duplication Warning Detection.
    Rinner C; Grossmann W; Sauter SK; Wolzt M; Gall W
    Biomed Res Int; 2015; 2015():380497. PubMed ID: 26682218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug drug interaction extraction from the literature using a recursive neural network.
    Lim S; Lee K; Kang J
    PLoS One; 2018; 13(1):e0190926. PubMed ID: 29373599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mining heterogeneous networks with topological features constructed from patient-contributed content for pharmacovigilance.
    Yang CC; Yang H
    Artif Intell Med; 2018 Aug; 90():42-52. PubMed ID: 30093253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol.
    Woosley RD; Romero K; Heise CW; Gallo T; Tate J; Woosley RL
    Drug Saf; 2019 Jul; 42(7):907-913. PubMed ID: 30888625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
    Khan Q; Ismail M; Haider I; Khan F
    Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting drug-drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system.
    Matsuo J; Yamaori S
    J Clin Pharm Ther; 2022 Jan; 47(1):70-80. PubMed ID: 34664726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.